中化化肥(00297.HK)擬不超4543萬美元採購不超7.7萬噸鉀肥
格隆匯3月3日丨中化化肥(00297.HK)發佈公吿,2022年3月3日,公司間接全資附屬公司中化澳門與Canpotex訂立出口合同,據此,中化澳門同意以每噸單價590美元的價格向Canpotex採購不超過7.7萬噸鉀肥,總對價不超過4543萬美元。
根據披露,Canpotex為一間合營公司,由兩家大型鉀肥生產商擁有——即Nutrien(於多倫多證券交易所及紐約證券交易所上市的公司)及The Mosaic Company(於紐約證券交易所上市的公司),並由兩家股東持有相等的股權。Canpotex是世界最大的鉀肥供應商的一,主要為其兩名股東從事鉀肥產品的海外市場推廣。
公吿稱,中國的鉀肥生產無法滿足國內需求。中國每年需進口適量鉀肥,以滿足中國國內農業生產對鉀肥的不斷增長需求。透過訂立本次交易,集團得以進一步豐富業務資源,並確保較稀有的礦物鉀肥的穩定供應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.